Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Olivier Hermine(Délégation Paris 5), Philippe Gaulard(Inserm)
Cited by 417
Related Papers
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
|PLoS ONE|2009|409
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
|Blood|2009|310
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
|The Journal of Experimental Medicine|2010|194